Publications
Below you can find a list of our published research.
Below you can find a list of our published research.
6128 results
Cited 8 times since 2008 (0.5 per year) source: EuropePMC
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], Volume 34, Issue 10, 27 4 2008, Pages 1333-1339 A prospective study of incidence of saphenous nerve injury after total great saphenous vein stripping. Flu HC, Breslau PJ, Hamming JF, Lardenoye JW
Background and objectives: Total stripping of the great saphenous vein (GSV) is a validated surgical strategy of treating patients with primary varicose veins (PVV). An often cited, but not well documented and studied, complication of total stripping is postoperative damage of the saphenous nerve (SN). Objective: The objective was to evaluate the incidence of SN damage and to assess the therapeutic efficacy after total stripping of the GSV. Materials and methods: Patients undergoing total stripp... Abstract
Cited 26 times since 2008 (1.6 per year) source: EuropePMC
Journal of vascular surgery, Volume 48, Issue 3, 24 4 2008, Pages 659-668 The effect of implementation of an optimized care protocol on the outcome of arteriovenous hemodialysis access surgery. Flu H, Breslau PJ, Krol-van Straaten JM, Hamming JF, Lardenoye JW
Background: The long-term patency of arteriovenous fistulas (AVFs) and arteriovenous grafts (AVGs) suffers from a high incidence of primary failure due to early thrombosis, myointimal hyperplasia at the venous access site, or failure to mature. A multidisciplinary meeting in vascular access surgery was initiated to optimize the timing, indication, type of intervention, and the logistics of AVFs/AVGs during the preoperative and postoperative period. This study evaluated the influence of the new o... Abstract
Cited 19 times since 2008 (1.1 per year) source: EuropePMC
European heart journal, Volume 29, Issue 16, 23 4 2008, Pages 2006-2013 Multi-slice computed tomography coronary angiography for ruling out suspected coronary artery disease: what is the prevalence of a normal study in a general clinical population? Henneman MM, Schuijf JD, van Werkhoven JM, Pundziute G, van der Wall EE, Jukema JW, Bax JJ
Aims: To assess the prevalence of a normal multi-slice computed tomography (MSCT) in patients with suspected coronary artery disease (CAD) and to relate these observations to clinical presentation and pre-test likelihood of CAD. Methods and results: In total, 340 consecutive patients (182 men, 55 +/- 12 years) without a history of CAD who were referred for MSCT angiography were included in the study. Based on patient characteristics and the referral reason for MSCT angiography, patients were cla... Abstract
Cited 37 times since 2008 (2.2 per year) source: EuropePMC
Journal of molecular and cellular cardiology, Volume 45, Issue 3, 21 3 2008, Pages 446-452 CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events. de Jager SC, Kraaijeveld AO, Grauss RW, de Jager W, Liem SS, van der Hoeven BL, Prakken BJ, Putter H, van Berkel TJ, Atsma DE, Schalij MJ, Jukema JW, Biessen EA
As chemokines are considered instrumental in thrombotic plaque rupture and erosion as well as in ischemia-reperfusion injury processes, we aimed to identify previously unknown chemokines associated with acute coronary syndromes. Plasma of 44 patients with acute myocardial infarction (AMI) and 22 controls were profiled for a panel of chemokines by multiplex analysis. Levels of CCL3 were prospectively verified in 54 patients with unstable angina pectoris (UAP). An AMI mouse model was used to asses... Abstract
Cited 7 times since 2008 (0.4 per year) source: EuropePMC
Nucleic acids research, Volume 36, Issue 13, 19 3 2008, Pages e83 Conditional gene vectors regulated in cis. Pich D, Humme S, Spindler MP, Schepers A, Hammerschmidt W
Non-integrating gene vectors, which are stably and extrachromosomally maintained in transduced cells would be perfect tools to support long-term expression of therapeutic genes but preserve the genomic integrity of the cellular host. Small extrachromosomal plasmids share some of these ideal characteristics but are primarily based on virus blueprints. These plasmids are dependent on viral trans-acting factors but they can replicate their DNA molecules in synchrony with the chromosome of the cellu... Abstract
Cited 71 times since 2008 (4.2 per year) source: EuropePMC
American journal of respiratory and critical care medicine, Volume 178, Issue 7, 19 3 2008, Pages 695-700 Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis. van Gestel YR, Hoeks SE, Sin DD, Welten GM, Schouten O, Witteveen HJ, Simsek C, Stam H, Mertens FW, Bax JJ, van Domburg RT, Poldermans D
Rationale: beta-Blocker use is associated with improved health outcomes in patients with cardiovascular disease. There is a general reluctance to prescribe beta-blockers in patients with chronic obstructive pulmonary disease (COPD) because they may worsen symptoms. Objectives: We investigated the relationship between cardioselective beta-blockers and mortality in patients with COPD undergoing major vascular surgery. Methods: We evaluated 3,371 consecutive patients who underwent major vascular su... Abstract
Cited 7 times since 2008 (0.4 per year) source: EuropePMC
The American journal of cardiology, Volume 102, Issue 6, 18 3 2008, Pages 718-721 Effects of interruption of long-term cardiac resynchronization therapy on left ventricular function and dyssynchrony. Ypenburg C, Van Bommel RJ, Marsan NA, Delgado V, Bleeker GB, van der Wall EE, Schalij MJ, Bax JJ
Interruption of short-term cardiac resynchronization therapy (CRT) has been shown to acutely worsen left ventricular (LV) function, mitral regurgitation, and LV dyssynchrony. The present study aims to assess whether LV reverse remodeling influences interruption of CRT, and, more practically, whether long-term continuous pacing is necessary in patients with reverse LV remodeling. A total of 135 recipients of CRT were selected after showing LV reverse remodeling defined as a decrease in LV end-sys... Abstract
Cited 1 times since 2008 (0.1 per year) source: EuropePMC
The international journal of cardiovascular imaging, Volume 24, Issue 7, 18 3 2008, Pages 761-762 Characterization of carotid plaques with a new CT technique. van der Laarse A, Bax JJ, van der Wall EE
Cited 70 times since 2008 (4.2 per year) source: EuropePMC
The Journal of clinical endocrinology and metabolism, Volume 93, Issue 9, 17 3 2008, Pages 3348-3356 Aortic valve calcification and mild tricuspid regurgitation but no clinical heart disease after 8 years of dopamine agonist therapy for prolactinoma. Kars M, Delgado V, Holman ER, Feelders RA, Smit JW, Romijn JA, Bax JJ, Pereira AM
Objective: Treatment with ergot-derived dopamine agonists, pergolide, and cabergoline has been associated with an increased frequency of valvular heart disease in Parkinson's disease. The aim of the present study was to assess the prevalence of valvular heart disease in patients treated with dopamine agonists for prolactinomas. Design: This was a cross-sectional study. Patients: We performed two-dimensional and Doppler echocardiography in 78 consecutive patients with prolactinoma (mean age... Abstract
Cited 34 times since 2008 (2 per year) source: EuropePMC
Current medical research and opinion, Volume 24, Issue 8, 17 3 2008, Pages 2151-2157 Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial--a prospective pilot study. de Bie MK, Lekkerkerker JC, van Dam B, Gaasbeek A, van Buren M, Putter H, van Erven L, Bax JJ, Schalij MJ, Rabelink TJ, Jukema JW
Objective: Sudden cardiac (arrhythmic) death (SCD) is the single largest cause of death in dialysis patients. Prophylactic Implantable Cardioverter Defibrillator (ICD) therapy reduces SCD and reduces all-cause mortality in several groups of patients at high risk for arrhythmic death. Whether this also applies to dialysis patients is unknown. Research design and methods: The Implantable Cardioverter Defibrillator in Dialysis patients (ICD2) trial is a prospective randomised controlled study. It h... Abstract
Cited 68 times since 2008 (4.1 per year) source: EuropePMC
Circulation, Volume 118, Issue 1, 16 3 2008, Pages 26-32 Gender and outcome in adult congenital heart disease. Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, Vliegen HW, van Dijk AP, Bouma BJ, Grobbee DE, Mulder BJ
Background: Gender differences in prognosis have frequently been reported in cardiovascular disease but less so in congenital heart disease. We investigated whether gender is associated with outcome in adult patients with congenital heart disease. Methods and results: From the CONgenital CORvitia (CONCOR) national registry for adults with congenital heart disease, 7414 patients were identified. All outcomes before entry into the registry and during subsequent follow-up were recorded, and differe... Abstract
Cited 15 times since 2008 (0.9 per year) source: EuropePMC
American journal of physiology. Heart and circulatory physiology, Volume 295, Issue 2, 13 2 2008, Pages H755-60 Biventricular pacing in chronic heart failure acutely facilitates the arterial baroreflex. Gademan MG, van Bommel RJ, Ypenburg C, Haest JC, Schalij MJ, van der Wall EE, Bax JJ, Swenne CA
Metabolic and mechanical stress in the failing heart activates the cardiac sympathetic afferent reflex (CSAR). It has been demonstrated that cardiac resynchronization therapy (CRT) acutely reduces MSNA in clinical responders. Mechanistically, this beneficial effect might be explained by acute deactivation of the CSAR. In addition to sympathoexcitation, CSAR inhibits the arterial baroreflex at the level of the nucleus tractus solitarii. Hence, in responders, CRT is likely to remove/reduce this in... Abstract
Cited 90 times since 2008 (5.4 per year) source: EuropePMC
Circulation research, Volume 103, Issue 2, 12 2 2008, Pages 167-176 Forced alignment of mesenchymal stem cells undergoing cardiomyogenic differentiation affects functional integration with cardiomyocyte cultures. Pijnappels DA, Schalij MJ, Ramkisoensing AA, van Tuyn J, de Vries AA, van der Laarse A, Ypey DL, Atsma DE
Alignment of cardiomyocytes (CMCs) contributes to the anisotropic (direction-related) tissue structure of the heart, thereby facilitating efficient electrical and mechanical activation of the ventricles. This study aimed to investigate the effects of forced alignment of stem cells during cardiomyogenic differentiation on their functional integration with CMC cultures. Labeled neonatal rat (nr) mesenchymal stem cells (nrMSCs) were allowed to differentiate into functional heart muscle cells in dif... Abstract
Cited 4 times since 2008 (0.2 per year) source: EuropePMC
Clinical pediatrics, Volume 47, Issue 9, 10 2 2008, Pages 856-860 Attitudes of parents and physicians toward febrile seizures. Yilmaz D, Arhan E, Yuksel D, Ozçelik A, Senbil N, Serdaroglu A, Gurer YK
Objectives: Although febrile seizures are common in children, attitudes may change among parents. The management of a child may differ depending on the specialty of the attending physician. This study was carried out to analyze attitudes of Turkish parents and physicians toward febrile seizures. Material and methods: 308 children with febrile seizure who were admitted to the Department of Pediatric Neurology at Dr Sami Ulus Children's Hospital and Gazi University in Turkey between January 2... Abstract
Cited 31 times since 2008 (1.9 per year) source: EuropePMC
Vaccine, Volume 26, Issue 33, 6 1 2008, Pages 4224-4230 Immunogenicity and efficacy of two candidate human metapneumovirus vaccines in cynomolgus macaques. Herfst S, Schrauwen EJ, de Graaf M, van Amerongen G, van den Hoogen BG, de Swart RL, Osterhaus AD, Fouchier RA
Human metapneumovirus (HMPV) is an important cause of acute respiratory tract disease for which the development of vaccine candidates is warranted. We have previously described the generation of an iscom matrix-adjuvanted HMPV fusion protein subunit vaccine (Fsol) and a live-attenuated vaccine (HMPVM11). Here, we evaluate the immunogenicity and efficacy of these vaccines in cynomolgus macaques. Immunization with Fsol induced HMPV F-specific antibody responses, virus neutralizing antibody titers,... Abstract
Cited 42 times since 2008 (2.5 per year) source: EuropePMC
Current gene therapy, Volume 8, Issue 3, 1 1 2008, Pages 147-161 Episomal vectors for gene therapy. Ehrhardt A, Haase R, Schepers A, Deutsch MJ, Lipps HJ, Baiker A
The increasing knowledge of the molecular and genetic background of many different human diseases has led to the vision that genetic engineering might be used one day for their phenotypic correction. The main goal of gene therapy is to treat loss-of-function genetic disorders by delivering correcting therapeutic DNA sequences into the nucleus of a cell, allowing its long-term expression at physiologically relevant levels. Manifold different vector systems for the therapeutic gene delivery have b... Abstract
Cited 10 times since 2008 (0.6 per year) source: EuropePMC
The Journal of thoracic and cardiovascular surgery, Volume 135, Issue 6, 1 1 2008, Pages 1247-52; discussion 1252-3 Magnetic resonance imaging assessment of reverse left ventricular remodeling late after restrictive mitral annuloplasty in early stages of dilated cardiomyopathy. Westenberg JJ, Braun J, Van de Veire NR, Klautz RJ, Versteegh MI, Roes SD, van der Geest RJ, de Roos A, van der Wall EE, Reiber JH, Bax JJ, Dion RA
Objective: Magnetic resonance imaging was used to evaluate left ventricular reverse remodeling at long-term follow-up (3-4 years) after restrictive mitral annuloplasty in patients with early stages of nonischemic, dilated cardiomyopathy, and severe mitral regurgitation. Methods: Twenty-two selected patients (eligible to undergo magnetic resonance imaging) with mild to moderate heart failure (mean New York Heart Association class 2.2 +/- 0.4), dilated cardiomyopathy (left ventricular ejection fra... Abstract
Cited 10 times since 2008 (0.6 per year) source: EuropePMC
Pediatric hematology and oncology, Volume 25, Issue 4, 1 1 2008, Pages 301-311 Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K
Coagulopathy is an important cause of mortality in critically ill children. Traditional therapies to correct coagulopathy lead to great time delays and cause fluid overload in patients. The authors report the effectiveness and safety of the activated recombinant factor VII (rFVIIa) administration in a series of 13 nonhemophiliac children with acute, life-threatening bleeding. In this retrospective study, the records of the patients who were not diagnosed with congenital hemorrhagic disorder and... Abstract
Cited 28 times since 2008 (1.7 per year) source: EuropePMC
Circulation, Volume 117, Issue 22, 27 4 2008, Pages 2850-2858 Accessory atrioventricular myocardial connections in the developing human heart: relevance for perinatal supraventricular tachycardias. Hahurij ND, Gittenberger-De Groot AC, Kolditz DP, Bökenkamp R, Schalij MJ, Poelmann RE, Blom NA
Background: Fetal and neonatal atrioventricular (AV) reentrant tachycardias can be life-threatening but resolve in most cases during the first year of life. The transient presence of accessory AV myocardial connections during annulus fibrosus development may explain this phenomenon. Methods and results: A total of 45 human embryonic, fetal, and neonatal sectioned hearts (4 to 36 weeks of development) were studied immunohistochemically. Accessory myocardial AV connections were quantified and cate... Abstract
Cited 57 times since 2008 (3.4 per year) source: EuropePMC
Annals of vascular surgery, Volume 22, Issue 4, 27 4 2008, Pages 582-597 Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation. van Weel V, van Tongeren RB, van Hinsbergh VW, van Bockel JH, Quax PH
Stimulation of vascular growth to treat limb ischemia is promising, and early results obtained from uncontrolled clinical trials using angiogenic agents, e.g., vascular endothelial growth factor, led to high expectations. However, negative results from recent placebo-controlled trials warrant further research. Here, current insights into mechanisms of vascular growth in the adult, in particular the role of angiogenic factors, the immune system, and bone marrow, were reviewed, together with modes... Abstract